Skip to main content
. 2012 Sep 4;7(9):e43824. doi: 10.1371/journal.pone.0043824

Figure 9. Induction of ERK1/2 phosphorylation by ribavirin correlated with p53 phosphorylation and suppression of HCV replication.

Figure 9

(A) Dose-dependent phosphorylation of ERK1/2 by ribavirin. HepG2 cells were treated for 24 h with the indicated doses of ribavirin. (B) The association of ribavirin-induced ERK1/2 phosphorylation with p53 phosphorylation in a time-course analysis. HepG2 cells were untreated or treated with 30 µg/ml ribavirin and then harvested at the indicated time points. In addition, we used small-interference RNA (siRNA) to knockdown ERK1/ERK2 to assess the role of ERK1/2 and p53 in the suppression of HCV replication. (C) Cells were transduced with ERK1/2-siRNA (100 nM) and scrambled-siRNA for 48 h and treated with ribavirin (100 µg/ml) for 24 h in HCV replicon cells (JFH1/HepG2) and HepG2 cells. Cells were lysed, and analyzed for the expression of phosphorylated ERK1/2 (ERK1/2∼pi), phosphorylated p53 at Ser15 (p53ser15∼pi), p53, ERK1/2, Mdm2 and HCV NS3 proteins by immunoblotting. (D) HCV RNA expression levels of scramble-siRNA- or si-ERK1/2-transduced cells with/without ribavirin treatment were determined using quantitative RT-PCR. Each result represents the mean ± s.e.m of 5 independent measurements and is considered statistically significant at P<0.05. Control: no ribavirin treatment, RBV: ribavirin.